WAVE LIFE SCIENCES LTD. Investment Income, Interest
WAVE LIFE SCIENCES LTD. (WVE) reported Investment Income, Interest of $4.72 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-07-30
- WAVE LIFE SCIENCES LTD. investment income, interest for the quarter ending 2026-06-30 was $4.72M, a 99.07% increase year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, interest for the quarter ending 2026-03-31 was $5.29M, a 84.03% increase year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, interest for the quarter ending 2025-09-30 was $2.18M, a 21.08% increase year-over-year.
- WAVE LIFE SCIENCES LTD. investment income, interest for the quarter ending 2025-06-30 was $2.37M, a 13.38% increase year-over-year.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month |
|---|---|---|---|
| 2026-06-30 | $4.72M 10-Q · filed 2026-07-30 | $10.01M 10-Q · filed 2026-07-30 | |
| 2026-03-31 | $5.29M 10-Q · filed 2026-04-28 | ||
| 2025-09-30 | $2.18M 10-Q · filed 2025-11-10 | $4.55M derived: sum of 2 quarters · filed 2026-07-30 | $7.42M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $2.37M 10-Q · filed 2026-07-30 | $5.25M 10-Q · filed 2026-07-30 | |
| 2025-03-31 | $2.88M 10-Q · filed 2026-04-28 | ||
| 2024-09-30 | $1.80M 10-Q · filed 2025-11-10 | $3.89M derived: sum of 2 quarters · filed 2025-11-10 | $6.42M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $2.09M 10-Q · filed 2025-07-30 | $4.63M 10-Q · filed 2025-07-30 | |
| 2024-03-31 | $2.54M 10-Q · filed 2025-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |